Source of iron overload in multiple sclerosis

The pathophysiology and pharmacology of hepcidin

(2014) Piotr Ruchala et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Physiological implications of NTBI uptake by T lymphocytes

(2014) Jorge P. Pinto et al.   Frontiers in Pharmacology

Inflammation alters the expression of DMT1, FPN1 and hepcidin, and it causes iron accumulation in central nervous system cells

(2013) Pamela Urrutia et al.   JOURNAL OF NEUROCHEMISTRY

Protective effect of mitochondrial ferritin on cytosolic iron dysregulation induced by doxorubicin in HeLa cells

(2013) Emiliano Cocco et al.   MOLECULAR BIOLOGY REPORTS

M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination

(2013) Veronique E Miron et al.   NATURE NEUROSCIENCE

Iron Is a Sensitive Biomarker for Inflammation in Multiple Sclerosis Lesions

(2013) Veela Mehta et al.   PLoS One

Iron levels in polarized macrophages: Regulation of immunity and autoimmunity

(2012) Stefania Recalcati et al.   AUTOIMMUNITY REVIEWS

Surface markers of lymphocyte activation and markers of cell proliferation

(2011) Maria Shipkova et al.   CLINICA CHIMICA ACTA

Hepcidin messenger RNA expression in human lymphocytes

(2010) Jorge P Pinto et al.   IMMUNOLOGY

Altered M1/M2 activation patterns of monocytes in severe relapsing experimental rat model of multiple sclerosis. Amelioration of clinical status by M2 activated monocyte administration

(2010) Joanna Mikita et al.   Multiple Sclerosis Journal